Validation of genome-wide prostate cancer associations in men of african descent

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 1, 2011, Pages 23-32

  Chang, Bao Li ^a   Spangler, Elaine ^a   Gallagher, Stephen ^a   Haiman, Christopher A ^b   Henderson, Brian ^b   Isaacs, William ^c   Benford, Marnita L ^d   Kidd, Lacreis R ^d   Cooney, Kathleen ^e   Strom, Sara ^f   Ingles, Sue Ann ^b   Stern, Mariana C ^b   Corral, Roman ^b   Joshi, Amit D ^b   Xu, Jianfeng ^g   Giri, Veda N ^h   Rybicki, Benjamin ⁱ   Neslund Dudas, Christine ⁱ   Kibel, Adam S ^j   Thompson, Ian M ^k   Leach, Robin J ^k   Ostrander, Elaine A ^l   Stanford, Janet L ^m   Witte, John ⁿ   Casey, Graham ^b   Eeles, Rosalind ^o   Hsing, Ann W ^p   Chanock, Stephen ^p   Hu, Jennifer J ^q   John, Esther M ^r   Park, Jong ^s   Stefflova, Klara ^a   Zeigler Johnson, Charnita ^a   Rebbeck, Timothy R ^a,t   more..

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF LOUISVILLE   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g WAKE FOREST UNIVERSITY   (United States)

^h FOX CHASE CANCER CENTER   (United States)

ⁱ HENRY FORD HOSPITAL   (United States)

^j WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k University of Texas Health Science Center at San Antonio   (United States)

^l NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^m USA   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^p NATIONAL CANCER INSTITUTE   (United States)

^q UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^r NORTHERN CALIFORNIA CANCER CENTER   (United States)

^s H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^t UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA MICROSEMINOPROTEIN; ZINC FINGER PROTEIN;

ARTICLE; CANCER SUSCEPTIBILITY; CHROMOSOME 8Q; CONTROLLED STUDY; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NUDT10 GENE; NUDT11 GENE; POPULATION GENETICS; PRIORITY JOURNAL; PROSTATE CANCER; VALIDATION PROCESS;

AFRICAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GREAT BRITAIN; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; UNITED STATES;

EID: 78651419461     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0698     Document Type: Article

References (58)

1. Gudmundsson J, Sulem P, Rafnar T, Bergthorsson JT, Manolescu A, Gudbjartsson D, et al. (2008). Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet 40, 281-283. (Pubitemid 351311771)
2. Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, Jugurnauth SK, et al. (2008). Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 40, 316-321.
3. Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N, et al. (2008). Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 40, 310-315.
4. Duggan D, Zheng SL, Knowlton M, Benitez D, Dimitrov L, Wiklund F, et al. (2007). Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst 99, 1836-1844.
5. Lou H, Yeager M, Li H, Bosquet JG, Hayes RB, Orr N, et al. (2009). Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility. Proc Natl Acad Sci U S A 106, 7933-7938.
6. Zheng SL, Stevens VL, Wiklund F, Isaacs SD, Sun J, Smith S, et al. (2009). Two independent prostate cancer risk-associated Loci at 11q13. Cancer Epidemiol Biomarkers Prev 18, 1815-1820.
7. Sun J, Zheng SL, Wiklund F, Isaacs SD, Purcell LD, Gao Z, et al. (2008). Evidence for two independent prostate cancerrisk-associated loci in the HNF1B gene at 17q12. Nat Genet 40, 1153-1155.
8. Gudmundsson J, Sulem P, Steinthorsdottir V, Bergthorsson JT, Thorleifsson G, Manolescu A, et al. (2007). Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 39, 977-983.
9. Hsu FC, Sun J, Wiklund F, Isaacs SD, Wiley KE, Purcell LD, Gao, et al. (2009). A Novel Prostate Cancer Susceptibility Locus at 19q13. Cancer Res 69, 2720-2723.
10. Al Olama AA, Kote-Jarai Z, Giles GG, Guy M, Morrison J, Severi G, et al. (2009). Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet 41, 1058-1060.
11. Haiman CA, Patterson N, Freedman ML, Myers SR, Pike MC, Walis-zewska A, et al. (2007). Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet 39, 638-644.
12. Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, Severi G, Muir K, Hopper JL, Henderson BE, Haiman CA, et al. (2009). Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet 41, 1116-1121.
13. Gudmundsson J, Sulem P, Gudbjartsson DF, Blondal T, Gylfason A, Agnarsson BA, et al. (2009). Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat Genet 41, 1122-1126.
14. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, Wacholder S, et al. (2007). Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 39, 645-649.
15. Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA, et al. (2006). A common variant associated with prostate cancer in European and African populations. Nat Genet 38, 652-658.
16. Yeager M, Chatterjee N, Ciampa J, Jacobs KB, Gonzalez-Bosquet J, Hayes RB, et al. (2009). Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet 41, 1055-1057.
17. Kote-Jarai Z, Easton DF, Stanford JL, Ostrander EA, Schleutker J, Ingles SA, et al. (2008). Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium. Cancer Epidemiol Biomarkers Prev 17, 2052-2061.
18. Freedman ML, Haiman CA, Patterson N, McDonald GJ, Tandon A, Waliszewska A, et al. (2006). Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci U S A 103, 14068-14073.
19. Waters KM, Le Marchand L, Kolonel LN, Monroe KR, Stram DO, Henderson BE, et al. (2009). Generalizability of associations from prostate cancer genome-wide association studies in multiple populations. Cancer Epidemiol Biomarkers Prev 18, 1285-1289.
20. Liu X, Plummer SJ, Nock NL, Casey G, and Witte JS. (2006). Non-steroidal antiinflammatory drugs and decreased risk of advanced prostate cancer: modification by lymphotoxin alpha. Am J Epidemiol 164, 984-989.
21. Stanford JL, Wicklund KG, McKnight B, Daling JR, and Brawer MK, et al. (1999). Vasectomy and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 8, 881-886.
22. Agalliu I, Salinas CA, Hansten PD, Ostrander EA, and Stanford JL, et al. (2008). Statin use and risk of prostate cancer: results from a population-based epidemiologic study. Am J Epidemiol 168,250-260.
23. Giri VN, Beebe-Dimmer J, Buyyounouski M, Konski A, Feigenberg SJ, Uzzo RG, et al. (2007). Prostate cancer risk assessment program: a 10-year update of cancer detection. J Urol 178, 1920-1924; discussion 1924.
24. Cooney KA, Strawderman MS, Wojno KJ, Doerr KM, Taylor A, Alcser KH, et al. (2001). Age-specific distribution of serum prostate-specific antigen in a community-based study of African-American men. Urology 57, 91-96.
25. Heeringa SG, Alcser KH, Doerr K, Strawderman M, Cooney K, Medb- ery B, and Schottenfeld D. (2001). Potential selection bias in a community-based study of PSA levels in African-American men. J Clin Epidemiol 54, 142-148.
26. Rybicki BA, Neslund-Dudas C, Nock NL, Schultz LR, Eklund L, Rosbolt J, et al. (2006). Prostate cancer risk from occupational exposure to polycyclic aromatic hydrocarbons interacting with the GSTP1 Ile105Val polymorphism. Cancer Detect Prev 30, 412-422.
27. Schwartz G, John E, Rowland G, and Ingles S. (2010). Schwartz GG, John EM, Rowland G Ingles SA. Prostate cancer in African American men and polymorphism in the calcium sensing receptor. Cancer Biology & Therapy (in press).
28. Benford ML, VanCleave TT, Lavender NA, Kittles RA, and Kidd LR. (2010) 8q24 sequence variants in relation to prostate cancer risk among men of African descent: a case-control study. BMC Cancer 10, 334.
29. Strom SS, Yamamura Y, Flores-Sandoval FN, Pettaway CA, and Lopez DS. (2008). Prostate cancer in Mexican-Americans: identification of risk factors. Prostate 68, 563-570.
30. Kolonel LN, Henderson BE, Hankin JH, Nomura AM, Wilkens LR, Pike MC, et al. (2000). A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol 151, 346-357.
31. Park JY, Tanner JP, Sellers TA, Huang Y, Stevens CK, Dossett N, et al. (2007). Association between polymorphisms in HSD3B1 and UGT2B17 and prostate cancer risk. Urology 70, 374-379.
32. Rebbeck TR, Jaffe JM, Walker AH, Wein AJ, and Malkowicz SB. (1998). Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. [see comment] [erratum appears in J Natl Cancer Inst 1999 Jun 16;91(12):1082].
33. Journal of the National Cancer Institute 90, 1225-1229.
34. Beuten J, Gelfond JA, Franke JL, Weldon KS, Crandall AC, Johnson- Pais TL, et al. (2009). Single and multigenic analysis of the association between variants in 12 steroid hormone metabolism genes and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 18, 1869-1880.
35. Beuten J, Gelfond JA, Martinez-Fierro ML, Weldon KS, Crandall AC, Rojas-Martinez A, et al. (2009). Association of chromosome 8q variants with prostate cancer risk in Caucasian and Hispanic men. Carcinogenesis 30, 1372-1379.
36. John EM, Schwartz GG, Koo J, Van Den Berg D, and Ingles SA. (2005). Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. Cancer Res 65, 5470-5479.
37. Xu J, Kibel AS, Hu JJ, Turner AR, Pruett K, Zheng SL, et al. (2009). Prostate cancer risk associated loci in African Americans. Cancer Epidemiol Biomarkers Prev 18, 2145-2149.
38. Gudmundsson J, Sulem P, Manolescu A, Amundadottir LT, Gudb- jartsson D, Helgason A, et al. (2007). Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 39, 631-637.
39. Hsu FC, Sun J, Wiklund F, Isaacs SD, Wiley KE, Purcell LD, et al. (2009). A novel prostate cancer susceptibility locus at 19q13. Cancer Res 69, 2720-2723.
40. Chang BL, Cramer SD, Wiklund F, Isaacs SD, Stevens VL, Sun J, et al. (2009). Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk. Hum Mol Genet 18, 1368-1375.
41. Sun J, Zheng SL, Wiklund F, Isaacs SD, Li G, Wiley KE, et al. (2009). Sequence variants at 22q13 are associated with prostate cancer risk. Cancer Res 69, 10-15.
42. Zheng SL, Sun J, Cheng Y, Li G, Hsu FC, Zhu Y, et al. (2007). Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans. J Natl Cancer Inst 99, 1525-1533.
43. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. (2007). PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81, 559-575.
44. Haploview. http://www.broad.mit.edu/mpg/haploview
45. Salinas CA, Kwon E, Carlson CS, Koopmeiners JS, Feng Z, Karyadi DM, Ostrander EA, and Stanford JL. (2008). Multiple independent genetic variants in the 8q24 region are associated with prostate cancer risk. Cancer Epidemiol Biomarkers Prev 17, 1203-1213.
46. Parra EJ, Kittles RA, Argyropoulos G, Pfaff CL, Hiester K, Bonilla C, et al. (2001). Ancestral proportions and admixture dynamics in geographically defined African Americans living in South Carolina. Am J Phys Anthropol 114, 18-29.
47. Reich DE, Cargill M, Bolk S, Ireland J, Sabeti PC, Richter DJ, et al. (2001). Linkage disequilibrium in the human genome. Nature 411,199-204.
48. Nam RK, Reeves JR, Toi A, Dulude H, Trachtenberg J, Emami M, et al. (2006). A novel serum marker, total prostate secretory protein of 94 amino acids, improves prostate cancer detection and helps identify high grade cancers at diagnosis. J Urol 175, 1291-1297.
49. Reeves JR, Dulude H, Panchal C, Daigneault L, and Ramnani DM. (2006). Prognostic value of prostate secretory protein of 94 amino acids and its binding protein after radical prostatectomy. Clin Cancer Res 12, 6018-6022.
50. Yi-Ping F, Wei T, Jacobs K, Hayes R, Kraft P, Berndt S, et al. (2010). Refining the prostate cancer genetic association within the JAZF1 gene on chromosome 7p15.2. Cancer Epidemiol Biomarkers Prev 19, 1349-1355.
51. Koontz JI, Soreng AL, Nucci M, Kuo FC, Pauwels P, van Den Berghe H, et al. (2001). Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc Natl Acad Sci U S A 98,6348-6353.
52. Micci F, Walter CU, Teixeira MR, Panagopoulos I, Bjerkehagen B, Saeter G, and Heim S. (2003). Cytogenetic and molecular genetic analyses of endometrial stromal sarcoma: nonrandom involvement of chromosome arms 6p and 7p and confirmation ofJAZF1/JJAZ1 gene fusion in t(7;17). Cancer Genet Cytogenet 144, 119-124.
53. Micci F, Panagopoulos I, Bjerkehagen B, and Heim S. (2006). Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal sarcoma. Cancer Res 66, 107-112.
54. Oliva E, de Leval L, Soslow RA, and Herens C. (2007). High frequency of JAZF1-JJAZ1 gene fusion in endometrial stromal tumors with smooth muscle differentiation by interphase FISH detection. Am J Surg Pathol 31, 1277-1284.
55. Hooker S, Hernandez W, Chen H, Robbins C, Torres JB, Ahaghotu C, et al. Replication of prostate cancer risk loci on 8q24, 11q13, 17q12, 19q33, and Xp11 in African Americans. Prostate 70, 270-275.
56. Haiman CA, Le Marchand L, Yamamato J, Stram DO, Sheng X, Kolonel LN, et al. (2007). A common genetic risk factor for colorectal and prostate cancer. Nat Genet 39, 954-956.
57. Robbins C,Torres JB, Hooker S, Bonilla C, Hernandez W, Candreva A, et al. (2007). Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus. Genome Res 17, 1717-1722.
58. Kader AK, Sun J, Isaacs SD, Wiley KE, Yan G, Kim ST, et al. (2009). Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients. Prostate 69, 1195-1205.